Product

Icosapent ethyl

Aliases
Vascepa

3 clinical trials

6 indications

Indication
COVID-19
Indication
Atherosclerosis
Clinical trial
Impact of Icosapent Ethyl on Alzheimers Disease Biomarkers in Preclinical Adults
Status: Completed, Estimated PCD: 2023-09-29
Clinical trial
IcoSApent ethyL to Slow Down Aortic VAlve Stenosis proGrEssion
Status: Recruiting, Estimated PCD: 2026-07-01